These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 32032851)
1. Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships. Wang R; Chen H; Yan W; Zheng M; Zhang T; Zhang Y Eur J Med Chem; 2020 Mar; 190():112109. PubMed ID: 32032851 [TBL] [Abstract][Full Text] [Related]
2. The Antiproliferative Activity of Ferrocene Derivatives against Drug- Resistant Cancer Cell Lines: A Mini Review. Li L; Ma L; Sun J Curr Top Med Chem; 2021; 21(19):1756-1772. PubMed ID: 34323188 [TBL] [Abstract][Full Text] [Related]
3. Ferrocene-appended pharmacophores: an exciting approach for modulating the biological potential of organic scaffolds. Singh A; Lumb I; Mehra V; Kumar V Dalton Trans; 2019 Feb; 48(9):2840-2860. PubMed ID: 30663743 [TBL] [Abstract][Full Text] [Related]
4. Current scenario of ferrocene-containing hybrids for antimalarial activity. Xiao J; Sun Z; Kong F; Gao F Eur J Med Chem; 2020 Jan; 185():111791. PubMed ID: 31669852 [TBL] [Abstract][Full Text] [Related]
5. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity. Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779 [TBL] [Abstract][Full Text] [Related]
6. Ferrocene-Based Compounds with Antimalaria/Anticancer Activity. Peter S; Aderibigbe BA Molecules; 2019 Oct; 24(19):. PubMed ID: 31591298 [TBL] [Abstract][Full Text] [Related]
7. Novobiocin-ferrocene conjugates possessing anticancer and antiplasmodial activity independent of HSP90 inhibition. Mbaba M; de la Mare JA; Sterrenberg JN; Kajewole D; Maharaj S; Edkins AL; Isaacs M; Hoppe HC; Khanye SD J Biol Inorg Chem; 2019 Mar; 24(2):139-149. PubMed ID: 30542925 [TBL] [Abstract][Full Text] [Related]
8. Has Ferrocene Really Delivered Its Role in Accentuating the Bioactivity of Organic Scaffolds? Sharma B; Kumar V J Med Chem; 2021 Dec; 64(23):16865-16921. PubMed ID: 34792350 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, docking, machine learning and antiproliferative activity of the 6-ferrocene/heterocycle-2-aminopyrimidine and 5-ferrocene-1H-Pyrazole derivatives obtained by microwave-assisted Atwal reaction as potential anticancer agents. Filho EV; Pina JWS; Antoniazi MK; Loureiro LB; Ribeiro MA; Pinheiro CB; Guimarães CJ; de Oliveira FCE; Pessoa C; Taranto AG; Greco SJ Bioorg Med Chem Lett; 2021 Sep; 48():128240. PubMed ID: 34217828 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy. Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323 [TBL] [Abstract][Full Text] [Related]
11. Effect of Regiochemistry and Methylation on the Anticancer Activity of a Ferrocene-Containing Organometallic Nucleoside Analogue. Ismail MK; Khan Z; Rana M; Horswell SL; Male L; Nguyen HV; Perotti A; Romero-Canelón I; Wilkinson EA; Hodges NJ; Tucker JHR Chembiochem; 2020 Sep; 21(17):2487-2494. PubMed ID: 32255248 [TBL] [Abstract][Full Text] [Related]
12. Ferrocenyl and organic novobiocin derivatives: Synthesis and their in vitro biological activity. Mbaba M; Mabhula AN; Boel N; Edkins AL; Isaacs M; Hoppe HC; Khanye SD J Inorg Biochem; 2017 Jul; 172():88-93. PubMed ID: 28441548 [TBL] [Abstract][Full Text] [Related]
13. Structure-property and structure-activity relationships of phenylferrocene derivatives as androgen receptor antagonists. Ochiai K; Fujii S Bioorg Med Chem Lett; 2021 Aug; 46():128141. PubMed ID: 34048883 [TBL] [Abstract][Full Text] [Related]
14. Assessment of the antitumor activity of a cyclopalladated ferrocene compound assisted by a dual-targeting drug delivery system. Gong G; Cao Y; Qian H; Zhou Y; Zhao H; Li L; Wang F; Zhao G Chem Commun (Camb); 2018 Jul; 54(60):8312-8315. PubMed ID: 29868665 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel ferrocene-quinoline conjugates and evaluation of their electrochemical and antiplasmodium properties. Minić A; Van de Walle T; Van Hecke K; Combrinck J; Smith PJ; Chibale K; D'hooghe M Eur J Med Chem; 2020 Feb; 187():111963. PubMed ID: 31865015 [TBL] [Abstract][Full Text] [Related]
16. Recent Advances in β-lactam Derivatives as Potential Anticancer Agents. Zhang X; Jia Y Curr Top Med Chem; 2020; 20(16):1468-1480. PubMed ID: 32148196 [TBL] [Abstract][Full Text] [Related]
17. Ferrocene-Appended Iridium(III) Complexes: Configuration Regulation, Anticancer Application, and Mechanism Research. Ge X; Chen S; Liu X; Wang Q; Gao L; Zhao C; Zhang L; Shao M; Yuan XA; Tian L; Liu Z Inorg Chem; 2019 Oct; 58(20):14175-14184. PubMed ID: 31559820 [TBL] [Abstract][Full Text] [Related]
18. Ferrocene Derivatives as New Generation of Antimalarial Agents: Opportunity or Illusion? Mangawa SK; Singh S Curr Top Med Chem; 2023; 23(16):1503-1521. PubMed ID: 36852796 [TBL] [Abstract][Full Text] [Related]